|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.610 CNY | +3.44% |
|
+14.24% | -9.30% |
| Market Cap | 2.83B 418M 365M 338M 310M 587M 40.28B 597M 4.03B 1.58B 19.67B 1.57B 1.54B 67.91B | P/E 2024 |
-8.86x | P/E 2025 | -9.48x |
|---|---|---|---|---|---|
| Enterprise Value | 3.05B 450M 393M 364M 334M 632M 43.37B 643M 4.34B 1.7B 21.18B 1.69B 1.65B 73.12B | EV / Sales 2024 |
1.48x | EV / Sales 2025 | 1.79x |
| Free-Float |
68.56% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +3.44% | ||
| 1 week | +14.24% | ||
| Current month | +21.55% | ||
| 1 month | +9.73% | ||
| 3 months | -24.16% | ||
| 6 months | -12.17% | ||
| Current year | -9.30% |
| 1 week | 3.07 |  | 3.64 |
| 1 month | 2.85 | | 3.64 |
| Current year | 2.85 | | 5.27 |
| 1 year | 2.85 | | 5.27 |
| 3 years | 2.76 | | 6.15 |
| 5 years | 2.76 | | 8.8 |
| 10 years | 2.76 | | 20.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ya Qi Dou
CEO | Chief Executive Officer | 42 | 2021-05-12 |
Xianti Zeng
DFI | Director of Finance/CFO | 52 | 2024-09-05 |
Zhi Wei Wang
PRN | Corporate Officer/Principal | 56 | 2019-09-16 |
| Director | Title | Age | Since |
|---|---|---|---|
Qi Ling Dou
CHM | Chairman | 66 | 2009-01-21 |
Zhi Wei Wang
BRD | Director/Board Member | 56 | 2011-02-20 |
Ya Qi Dou
BRD | Director/Board Member | 42 | 2019-01-02 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.44% | +14.24% | -10.64% | -30.98% | 404M | |
| +1.08% | -3.84% | +51.50% | +160.13% | 1,031B | |
| +1.19% | -5.10% | +61.09% | +56.36% | 595B | |
| +4.21% | +0.65% | +36.48% | +87.04% | 431B | |
| +0.42% | -0.99% | +30.04% | +22.27% | 326B | |
| +1.03% | -2.10% | +28.32% | +45.08% | 277B | |
| +0.49% | -11.32% | +20.31% | +22.32% | 263B | |
| +1.59% | +3.91% | -22.47% | -36.84% | 224B | |
| +3.70% | +0.98% | +27.03% | +63.38% | 193B | |
| +3.49% | +0.35% | +24.98% | +76.58% | 164B | |
| Average | +1.81% | -2.54% | +24.66% | +46.53% | 350.47B | |
| Weighted average by Cap. | +1.55% | -4.30% | +37.79% | +79.42% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.17B 321M 281M 259M 238M 451M 30.93B 458M 3.09B 1.22B 15.1B 1.21B 1.18B 52.14B | 1.86B 275M 240M 222M 204M 386M 26.5B 393M 2.65B 1.04B 12.94B 1.03B 1.01B 44.68B |
| Net income | -317M -46.83M -40.93M -37.86M -34.74M -65.74M -4.51B -66.89M -451M -177M -2.2B -176M -172M -7.61B | -330M -48.65M -42.53M -39.33M -36.09M -68.3M -4.69B -69.49M -469M -184M -2.29B -183M -179M -7.9B |
| Net Debt | 411M 60.66M 53.02M 49.03M 44.99M 85.16M 5.84B 86.64M 585M 230M 2.85B 228M 223M 9.85B | 217M 32.05M 28.02M 25.91M 23.77M 45M 3.09B 45.78M 309M 121M 1.51B 120M 118M 5.21B |
Employees
4,832
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-15 | CN¥3.610 | +3.44% | 42,692,840 |
| 26-07-15 | CN¥3.490 | +0.58% | 37,168,652 |
| 26-07-14 | CN¥3.470 | +2.06% | 30,082,403 |
| 26-07-13 | CN¥3.400 | +2.41% | 36,638,176 |
| 26-07-10 | CN¥3.320 | +5.40% | 35,226,991 |
- Stock Market
- Stocks
- 600594 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
